Ratings Moves: AIR,...
Health Care: Drugs
Illumina Inc. (ILMN: NASDAQ)
$72.00 2.35 | 3.37%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 72.00 |
| 52 Week High | 77.11 |
| 52 Week Low | 37.77 |
| Avg. Daily Vol. (Mil) | 1.33 |
| Beta (3 year) | 0.86 |
| Share Related Items | |
| Mkt Cap (Mil) | 8,955.25 |
| Shares Out (Mil) | 124.38 |
| Float (Mil) | 91.02 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.10 |
| Current Ratio | 3.80 |
| LT Debt/ Equity | 0.62 |
| Total Debt / Equity | 0.65 |
| Valuation Ratios | |
| Price Earnings | 96.00 |
| Price/Sales | 7.42 |
| Price/Book | 6.83 |
| Price/Cash Flow | 43.30 |
| Per Share Data | |
| Earnings | 0.75 |
| Sales | 9.70 |
| Book Value | 10.55 |
| Cash Flow | 1.66 |
| Business Summary | |
|---|---|
| Illumina, Inc. is developer, manufacturer and marketer of integrated systems for the large scale analysis of genetic variation and biological function. | |
| General Information | |
| 5200 Illumina Way
San Diego, CA 92121-1975 |
|
| www.illumina.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 2400 | |
| CEO: Jay T. Flatley | |
| Short Interest | |
| Current Month (Mil) | 29.02 |
| Previous Month (Mil) | 28.83 |
| Short Interest Ratio (Days) | 20.10 |
| Management Effectiveness | |
| Return on Equity | 7.80 |
| Return on Assets | 3.70 |
| Return on Investments | 4.80 |
| Profitability | |
| Gross Margin | 75.90 |
| EBIT Margin | 14.30 |
| Profit Margin | 8.50 |
Portfolios with ILMN
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserBender
- ContributorEarnings Short Squeeze Play...
- Contributor5 Stocks Hedge Funds Have B...
- ContributorMost-Searched Stocks for th...
- ContributorUptrending Short Squeeze Tr...
- Contributor15 Best Stocks at Top-Perfo...
- UserWatchlist
Latest ILMN Headlines from TheStreet
- Illumina Inc. (ILMN): Today's Featured Drugs Laggard 05.13.13 | 05:05 pm
- Illumina Rises On Unusually High Volume (ILMN) 05.10.13 | 03:05 pm
- Illumina Stock Hits New 52-Week High (ILMN) 05.08.13 | 12:05 pm
- Illumina Inc. (ILMN): Today's Featured Drugs Winner 05.06.13 | 05:05 pm
- Illumina Reaches New 52-Week High (ILMN) 04.30.13 | 12:04 pm
- Illumina Stock Hits New 52-Week High (ILMN) 04.23.13 | 10:04 am
- 5 Names Seeing Bullish Options Flow 04.18.13 | 12:04 pm
- Illumina Stock Hits New 52-Week High (ILMN) 04.10.13 | 04:04 pm
- Illumina Inc. (ILMN): Today's Featured Health Care Laggard 03.13.13 | 05:03 pm
- Illumina Inc. (ILMN): Today's Featured Drugs Winner 03.01.13 | 05:03 pm
Press Releases for ILMN
- Illumina Technology Enables Findings Of The Collaborative Oncological Gene-Environment Study (COGS) - Business Wire 03.27.13 | 12:03 pm
- Illumina Announces Favorable Outcome Of Its Patent Litigation Against Life Technologies, Inc. - Business Wire 03.21.13 | 04:03 pm
- Illumina Announces Outcome Of Its Patent Litigation Against Syntrix Biosystems, Inc. - Business Wire 03.14.13 | 09:03 pm
- Illumina Completes Acquisition Of Verinata Health - Business Wire 02.21.13 | 04:02 pm
- Illumina To Webcast Live Presentation At The Cowen And Company Annual Health Care Conference - Business Wire 02.20.13 | 06:02 am
- Illumina Reports Record Financial Results For Fourth Quarter And Fiscal Year 2012 - Business Wire 01.28.13 | 04:01 pm
- Illumina Announces Recipients Of Agricultural Greater Good Initiative Grants - Business Wire 01.15.13 | 06:01 pm
- Illumina To Announce Fourth Quarter And Fiscal Year 2012 Financial Results On Monday, January 28, 2013 - Business Wire 01.15.13 | 06:01 am
- Illumina Announces Sequencing Technology Innovations - Business Wire 01.08.13 | 12:01 pm
- Partners HealthCare And Illumina Announce Founding Members Of GeneInsight Network - Business Wire 01.07.13 | 02:01 pm
Partner Headlines for ILMN
- PerkinElmer, Inc. (PKI) Ex-Dividend Date Scheduled for April 17, 2013 - NASDAQ 04.16.13 | 01:04 pm
- Thermo Fisher Buying Life Tech At Premium Price - Investor's Business Daily 04.15.13 | 05:04 pm
- FEI Company (FEIC) Ex-Dividend Date Scheduled for April 08, 2013 - NASDAQ 04.05.13 | 01:04 pm
- Stocks Turn Mixed, Apple Rises; Stratasys, 3D Systems Tumbling - Investor's Business Daily 01.28.13 | 12:01 pm
- RIM, Green Mountain and Other Top Performing Nasdaq Stocks in November - Benzinga 12.01.12 | 01:12 pm
- Benzinga's M&A Chatter for Friday November 23, 2012 - Benzinga 11.24.12 | 10:11 am
- Benzinga's M&A Chatter for Wednesday November 21, 2012 - Benzinga 11.22.12 | 12:11 pm
- Parexel International Leads Medical Research Group - Investor's Business Daily 11.16.12 | 06:11 pm
- Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX) - Benzinga 11.12.12 | 01:11 pm
- Life Beats, FX Headwind Continues - Analyst Blog - Zacks 11.02.12 | 10:11 am
